SNHG1/miR‐21 axis mediates the cardioprotective role of aloin in sepsis through modulating cardiac cell viability and inflammatory responses

Abstract

AbstractBackgroundAloin has cardioprotective effects, however, its cardioprotective role in sepsis remains unclear. This study aimed to analyze whether aloin could prevent sepsis‐related myocardial damage and explore the underlying mechanisms by examining the expression of long‐noncoding RNA (lncRNA) SNHG1 and microRNA‐21 (miR‐21).MethodsThe interaction of SNHG1 with miR‐21 was identified by dual‐luciferase reporter assay. The levels of SNHG1 and miR‐21 were measured by real‐time quantitative PCR. The cardioprotective function of aloin was assessed in a sepsis animal model, which was induced by cecal ligation and puncture, and in a myocardial injury cell model in H9C2 cells stimulated by lipopolysaccharide. Myocardial injury biomarker levels and hemodynamic indicators in mice model were measured to evaluate cardiac function. The viability of H9C2 cells was assessed by cell counting kit‐8 assay. Inflammatory cytokine levels were examined by an ELISA method.ResultsDecreased SNHG1 and increased miR‐21 were found in sepsis patients with cardiac dysfunction, and they were negatively correlated. Aloin significantly attenuated myocardial damage and inflammatory responses of mice model, and increased the viability and suppressed inflammation in H9C2 cell model. In addition, SNHG1 expression was upregulated and miR‐21 expression was downregulated by aloin in both mice and cell models. Moreover, in mice and cell models, SNHG1/miR‐21 axis affected sepsis‐related myocardial damage, and mediated the cardioprotective effects of aloin.ConclusionOur findings indicated that aloin exerts protective effects in sepsis‐related myocardial damage through regulating cardiac cell viability and inflammatory responses via regulating the SNHG1/miR‐21 axis.